Verdict: TelosRx prices by commitment length rather than by dose, and publishes the ladder for exactly one of its four formulations. On oral tirzepatide it publishes $129/mo on the twelve-month plan and $229/mo on the one-month plan. On the other three you are given a floor and told your price depends on plan length, without being shown the lengths.
GLP1 Clinics may earn a commission from some provider links. Rankings and reviews are editorially independent.
Answer-first guidance. Skip to pricing, eligibility, or the full verdict.
The rate is set by how long you commit, not by your dose — and TelosRx publishes that ladder for one formulation out of four. On oral tirzepatide the published rates run from $129/mo on the twelve-month plan to $229/mo month to month. On the other three you get a floor and a sentence saying your price depends on plan length.
Oral tirzepatide is the only formulation whose plan table TelosRx publishes, so it is the only one we can show you in full. Each card states its first-month price, the rate that follows it, and how often you are billed. The other three formulations appear below the ladder as published floors, not as rungs — they are not directly comparable to these figures.
The only formulation with a published plan table. Rates below are quoted exactly as the cards state them.
Published as floors only. TelosRx states "Your price depends on plan length" but does not publish the lengths or the rates, so these are not rungs and should not be read against the ladder above.
Prices verified 30 Jul 2026 from telosrx.com. ALSO PUBLISHED, ON THE SAME PAGE: the hero above these cards reads "Starting from $49 first month", while every plan card reads "$0 first month". TelosRx publishes both figures simultaneously for the same product. We show both and select neither, we do not attach the $49 to any particular plan length, and we do not treat either promotion as guaranteed at checkout — checkout is not visible without starting an intake. The "$50 off first" and "$30 off first" badges are quoted as written and never subtracted from an ongoing rate to manufacture a first-month price.
| Medication | Form | Cost | Qualification |
|---|---|---|---|
| Oral tirzepatidecompounded, sublingual | Daily under-the-tongue dose | $129–$229/mo by plan length | The only formulation with a published plan table. Formulated with ondansetron, an anti-nausea medication. |
| Semaglutidecompounded | Weekly injection | As low as $99/mo | Floor only; TelosRx says the price depends on plan length but does not publish the table. |
| Microdosed tirzepatidecompounded, low dose | Weekly injection | As low as $116/mo | Floor only. Described by TelosRx as the gentlest start. |
| Injectable tirzepatidecompounded | Weekly injection | As low as $139/mo | Floor only. Described as the strongest, dual-pathway option. |
TelosRx states all four formulations are compounded from licensed US pharmacies and are not FDA-approved, and that prescribing is subject to medical approval by a licensed provider. Compounded drugs have not been reviewed by the FDA for safety, effectiveness or quality.
TelosRx describes it as five minutes online, with no appointment.
TelosRx states your intake is reviewed by a physician, typically within 4 hours.
TelosRx states the dose is tailored to your labs and goals rather than a flat template.
Shipped from a licensed US compounding pharmacy, with free 2-day shipping stated.
TelosRx states unlimited messaging with the care team and dose adjustments over time.
TelosRx states clinician review typically happens within 4 hours and shipping is free 48-hour, but publishes no end-to-end time from intake to first dose, so we do not estimate one.
Being unable to confirm something is not the same as it being untrue, and we do not present it as such. Scoring follows our published methodology.
On the oral tirzepatide page the hero reads "Starting from $49 first month" and every plan card reads "$0 first month". Both are live simultaneously. We publish both and choose neither, and we cannot see which one applies at checkout without starting an intake.
TelosRx states "Your price depends on plan length" on the semaglutide page, then publishes an "As low as" figure and no plan table. So $99, $116 and $139 are floors, not monthly rates, and nothing on the site says what the higher rungs cost.
The 3-month and 1-month cards carry "$50 off first" and "$30 off first" beside a "$0 first month" figure. We quote the badges as written and do not subtract them from the ongoing rate, because that would publish a number TelosRx does not state.
The semaglutide page shows $299 struck through beside $99. TelosRx never says whether $299 is ever charged, so it appears here as context and never as a bound.
TelosRx states this plainly for all four formulations: they are compounded from licensed US pharmacies and have not been reviewed by the FDA.
No insurance billing is described anywhere on the pages we read, and no prior-authorisation support is offered.
TelosRx states plainly that the monthly cost does not change as the clinician titrates you upward. What moves the number instead is how long you commit: on oral tirzepatide it publishes $129/mo on the twelve-month plan and $229/mo month to month.
The problem is that the ladder exists publicly for one formulation out of four. For semaglutide, microdosed tirzepatide and injectable tirzepatide you are shown an "As low as" figure and told your price depends on plan length, without being told the lengths or the rates. Those floors are not prices you can plan against, and we have not presented them as if they were.
There is also an unresolved contradiction on the page itself. The hero says "Starting from $49 first month"; all four plan cards say "$0 first month". Both are published at the same time for the same product. Neither is necessarily wrong, but you should confirm which applies before you enter a card, and treat the ongoing rate — not either promotion — as the number you are agreeing to.
Affiliate link. We may earn a commission at no cost to you. Our rating is set before any commercial relationship and never changes because of one.
Two first-month figures are published at once; the rate that follows is the one you commit to. Prices verified 30 Jul 2026; confirm current pricing on the provider's own site before you pay.
Affiliate link · commission does not affect our 7.5/10 rating
